Cellectis S.A.
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.300 EUR
−33.98 M EUR
38.37 M EUR
45.37 M
About Cellectis S.A.
Sector
Industry
CEO
André Choulika
Website
Headquarters
Paris
Founded
2000
IPO date
Feb 6, 2007
Identifiers
2
ISIN FR0010425595
Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and André Choulika on February 20, 1999 and is headquartered in Paris, France.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 0WA2 is 3.280 EUR — it has increased by 0.38% in the past 24 hours. Watch Cellectis S.A. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSIN exchange Cellectis S.A. stocks are traded under the ticker 0WA2.
0WA2 stock has fallen by −12.81% compared to the previous week, the month change is a −22.48% fall, over the last year Cellectis S.A. has showed a 112.71% increase.
We've gathered analysts' opinions on Cellectis S.A. future price: according to them, 0WA2 price has a max estimate of 8.57 EUR and a min estimate of 3.42 EUR. Watch 0WA2 chart and read a more detailed Cellectis S.A. stock forecast: see what analysts think of Cellectis S.A. and suggest that you do with its stocks.
0WA2 reached its all-time high on Apr 3, 2018 with the price of 29.570 EUR, and its all-time low was 0.910 EUR and was reached on Oct 31, 2023. View more price dynamics on 0WA2 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0WA2 stock is 1.83% volatile and has beta coefficient of 0.17. Track Cellectis S.A. stock price on the chart and check out the list of the most volatile stocks — is Cellectis S.A. there?
Today Cellectis S.A. has the market capitalization of 237.59 M, it has decreased by −6.30% over the last week.
Yes, you can track Cellectis S.A. financials in yearly and quarterly reports right on TradingView.
Cellectis S.A. is going to release the next earnings report on Mar 11, 2026. Keep track of upcoming events with our Earnings Calendar.
0WA2 earnings for the last quarter are 0.01 EUR per share, whereas the estimation was −0.20 EUR resulting in a 104.37% surprise. The estimated earnings for the next quarter are −0.25 EUR per share. See more details about Cellectis S.A. earnings.
Cellectis S.A. revenue for the last quarter amounts to 32.19 M EUR, despite the estimated figure of 8.19 M EUR. In the next quarter, revenue is expected to reach 9.71 M EUR.
0WA2 net income for the last quarter is 504.04 K EUR, while the quarter before that showed −20.93 M EUR of net income which accounts for 102.41% change. Track more Cellectis S.A. financial stats to get the full picture.
No, 0WA2 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 3, 2026, the company has 222 employees. See our rating of the largest employees — is Cellectis S.A. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Cellectis S.A. EBITDA is −13.62 M EUR, and current EBITDA margin is −116.23%. See more stats in Cellectis S.A. financial statements.
Like other stocks, 0WA2 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cellectis S.A. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cellectis S.A. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cellectis S.A. stock shows the buy signal. See more of Cellectis S.A. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.